United States
287 articles
FDA Dermal Filler Approvals and Adverse Events: A 30-Year MAUDE and PMA Analysis
A comprehensive, data-driven analysis of 1,038 FDA dermal filler PMA approvals and 22,247 adverse events from the MAUDE database, detailing trends, top brands, and safety profiles.
FDA Product Code FDT: A Quantitative Audit of Duodenoscope Recalls and MAUDE Events
An empirical, data-driven safety audit of FDA product code FDT (duodenoscopes). Analyze 31 classified recalls and 3,985 adverse events from the MAUDE database.
FDA Product Code NAY: Surgical Robotics Clearance and Recall Trends
A deep dive into FDA product code NAY (computer-assisted surgical systems) using active registry data. Learn about 510(k) clearance trends and recall root causes.
ISO 14971 Risk-Control Traceability: How to Spot and Fix Audit Gaps
Prepare your Risk Management File for FDA or Notified Body audits. Learn to classify, locate, and remediate risk-control traceability gaps before your next QMS inspection.
FDA 522 Postmarket Surveillance Studies: Section 522 Order Compliance Guide
Understand FDA Section 522 postmarket surveillance orders for Class II and III devices: triggering criteria, the 30-day plan and 15-month start rules, study design, and the public 522 database.
Medical Device Accessibility: ADA, Section 508, and EU Accessibility Act Guide
ADA Title II/III, Section 508, WCAG 2.1 AA, and the EU Accessibility Act applied to medical devices, SaMD, patient apps, and infusion-pump screens — what it means for device design.
FDA 510(k) Clearance Trends 1995-2026: Volume Stable as Traditional Submissions Take Share
Analysis of 175,149 FDA 510(k) clearances. Volume stabilized at roughly 3,200 per year after 2007, while Traditional submissions rose from 73% to 83% as Special and Abbreviated programs declined.
FDA Medical Device Recall Concentration: Top 50 Firms Drive Over Half of All Recalls
Analysis of 58,374 FDA recall records: recall burden is concentrated. The top 50 firms drive 52% of recalls while 42% of firms recalled only once. Zimmer Biomet, Philips, Stryker, and Medtronic lead.
FDA Orthopedic Implant Recalls: Zimmer Biomet Leads 3,167 Hip & Knee Recall Records
FDA recall analysis: 3,167 hip, knee, and shoulder joint-replacement recalls across 70 product codes. Zimmer Biomet holds 37%, the top-10 firms 87%, and 96% are Class II 510(k) devices, not PMA.
Investigational Device Rules Compared: FDA 21 CFR 812, EU MDR, SFDA & Health Canada
Side-by-side comparison of investigational device rules: FDA 21 CFR Part 812 IDE, EU MDR Articles 62-82, Saudi SFDA MDS-REQ 2, and Canada's Investigational Testing Authorization.
IVD Registration Compared: FDA 809, EU IVDR, China, Brazil & India
Side-by-side legal-text comparison of IVD registration: FDA 21 CFR Part 809, EU IVDR 2017/746, China SAMR Decree 48, Brazil RDC 830/2023, India MDR 2017 — classes, pathways, who reviews.
Adverse-Event Reporting Compared: FDA 21 CFR 803, EU MDR, Brazil, Thailand & SA
Side-by-side legal-text comparison of device adverse-event reporting: FDA 21 CFR 803, EU MDR Art. 87, Brazil RDC 67/2009, Thailand MoPH, SAHPRA — triggers, timelines, who must report.
QMS/GMP Compared: FDA QMSR, Brazil RDC 665, Mexico NOM-241 & China
Legal-text comparison of medical device quality systems: FDA 21 CFR Part 820 (QMSR), Brazil RDC 665/2022, Mexico NOM-241-SSA1-2025, and China Order 53 — scope, certification, and audit.
Recall vs FSCA Compared: FDA 21 CFR 806, EU MDR, Brazil & Thailand
Side-by-side legal-text comparison of medical device field actions: FDA 21 CFR Part 806, EU MDR FSCA/FSN, Brazil RDC 551/2021, and Thailand recall guidance — triggers, timelines, filing objects.
UDI & Labeling Compared: FDA 801/830, EU MDR, Mexico NOM-137 & China
Legal-text comparison of medical device UDI and labeling: FDA 21 CFR Parts 801 & 830, EU MDR Article 27/Annex VI, Mexico NOM-137-SSA1-2025, and China Order 6/2014 — carriers, databases, and language.
FDA Breast Implant Recalls: Allergan, BIA-ALCL, and the 580,000-Report MAUDE Record
Breast implant analysis: 16 Class I FDA recalls (Allergan BIOCELL), 1,380 BIA-ALCL cases, and 580,000 MAUDE reports. Capsular contracture and implant failure lead complications.
FDA Pacemaker and ICD Recalls: 451 Enforcement Actions and the Lead-Failure Record
Pacemaker and ICD analysis: 451 FDA enforcement actions (188 Class I) and 558,000 MAUDE reports. Boston Scientific and Medtronic lead; software and lead-impedance faults dominate Class I.
FDA Surgical Mesh Recalls: 171 Actions and the Polymeric-Mesh MAUDE Record
Surgical mesh analysis: 171 FDA recalls, 15 Class II enforcements, and 145,000 MAUDE reports. Bard/Davol leads recalls and reports; the POP-mesh 510(k) line was pulled to Class III in 2016.
FDA 510(k) by Medical Specialty: 8 Panels Control 68% of All Clearances
175,149 FDA 510(k) clearances analyzed by medical specialty: the top 8 panels control 68%, Cardiovascular leads all-time, and Radiology is the fastest-growing as imaging AI reshapes the mix.
Hemodialysis Recalls: 821 Events Show the Burden Sits in Disposables, Not Machines
FDA hemodialysis recall analysis: 821 events across 26 dialysis codes — 96.6% in disposables and catheters, not machines. 82 Class I actions; Fresenius and Baxter lead.